Accessibility Menu
Cartesian Growth II logo

Cartesian Growth II(NASDAQ) RENE

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+28%
5 YearN/A
1 Year+6%
1 Month+0%
N/A
Cartesian Growth II last closing stock price
MetricPriceDate
Last closeUSD 12.712026-07-21
Cartesian Growth II stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 12.712026-07-06
1 month+0%USD 12.712026-06-10
3 month+0%USD 12.712026-04-22
Year to date+4.61%USD 12.152025-12-30
1 year+5.56%USD 12.042025-07-21
3 year+18.9%USD 10.692023-07-21
Since inception+27.67%USD 9.962022-07-08

Cartesian Growth II Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$1.02M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

May 15, 2025

RENE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cartesian Growth II

Cartesian Growth Corporation II is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands. Its primary focus is to effect a business combination, such as a merger or acquisition, with businesses positioned for high growth and potential transnational operations. The company aims to leverage the experienced management team’s network and investment expertise to create value for its shareholders through strategic acquisitions and partnerships.

Products and Services

Merger or acquisition of high-growth companies across various industries.

Involving in transactions that potentially enhance shareholder value.

Capitalizing on management's networking and strategic advisory skills.

What Makes Cartesian Growth Corporation II Special

What sets Cartesian Growth Corporation II apart is its leadership team’s proven track record in identifying promising investment opportunities and executing strategic acquisitions. Its dedication to creating long-term value through partnerships with innovative and scalable businesses distinguishes it in the SPAC arena. The company also stands out due to its focus on sectors with substantial growth potential and operational efficiency.

Five Things You Need to Know

Cartesian Growth Corporation II completed its initial public offering in May 2022, raising $230 million.

It places emphasis on high-growth businesses with potential transnational operations.

Management has extensive experience and a global network beneficial for sourcing deals.

The company has until November 2024 to complete a business combination, with shareholders recently approving an extension.

The SPAC is backed by Cartesian Capital Group, known for its disciplined investment strategies and track record.

AI Generated • Apr 16, 2026

Industry

Capital Markets

Employees

2

CEO

Peter Michael Yu

Headquarters

New York City, NY 10017, US

RENE Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-7.12%

Return on Capital

N/A

Return on Assets

2.66%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$978.89K

EBITDA

-$775.28K

Operating Cash Flow

-$675.97K

Capital Expenditure

$0.00

Free Cash Flow

-$675.97K

Cash & ST Invst.

$105.29K

Total Debt

$0.00

Cartesian Growth II Performance Analysis

Cartesian Growth II annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Cartesian Growth II sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Cartesian Growth II annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.17N/A
20232023-12-31USD 0.41140.8%
20242024-12-31USD 0.40-2.2%
20252025-12-31USD -0.12N/A
Cartesian Growth II sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-126.0%
Q32025-09-30400.0%
Q42025-12-31-700.0%
Q12026-03-31294.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

$3.09M

+452.8%

EBITDA

-$242.43K

-24.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$105.29K

+29.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

2.66%

N/A

Return on Invested Capital

-3.01%

N/A

Free Cash Flow

-$57.57K

+63.0%

Operating Cash Flow

-$57.57K

+63.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BFACBattery Future Acquisition Corp.
$11.14+0.13%
BCSABlockchain Coinvestors Acquisition Corp. I
$11.58N/A
ICUSeaStar Medical Holding Corporation
$3.18+4.26%
ROSSRoss Acquisition Corp II
$11.08-0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$129.58+0.13%
TTDThe Trade Desk
$14.02-0.21%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.14+0.06%
NVDANvidia
$222.47+0.02%

Questions About RENE

What is the current price of Cartesian Growth II?

Cartesian Growth II is trading at N/A per share.

What is the 52-week range for Cartesian Growth II?

Over the past 52 weeks, Cartesian Growth II has traded between N/A and N/A.

How much debt does Cartesian Growth II have?

As of the most recent reporting period, Cartesian Growth II reported total debt of $9.24M.

How much cash does Cartesian Growth II have on hand?

Cartesian Growth II reported $105.29K in cash and cash equivalents in its most recent financial results.

What is Cartesian Growth II’s dividend yield?

Cartesian Growth II does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.